Taipei City Government approved the establishment of Pharmira Laboratories, Inc., with founding equity of NTD$55 million.
- Handa Pharmaceuticals Announces TruPharma’s U.S. Launch Of Its FDA-Approved ANDA for Lamotrigine Extended Release Tablets
- Handa Pharmaceuticals, Inc. Announces FDA Approval for Generic Version of AstraZeneca’s SEROQUEL XR® Extended Release Tablets
- Emerging Markets listing in Taiwan
- Taiwan Authorities Approve Public Issuance of Handa Stock
- Handa Pharmaceuticals Announces Endo Begins Shipping Generic Version of AstraZeneca’s SEROQUEL XR®